The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC.
Saved in:
| Title: | The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC. |
|---|---|
| Authors: | Patil T; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Staley A; University of Colorado Cancer Center Biostatistics Core, University of Colorado School of Medicine, Aurora, Colorado., Nie Y; Department of Medical Oncology, Yale School of Medicine, Yale University, New Haven, Connecticut., Sakamoto M; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Stalker M; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Jurica JM; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Koehler K; Division of Medical Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Cass A; Division of Medical Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Kuykendall H; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Schmitt E; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Filar E; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Reventaite E; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Davies KD; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Nijmeh H; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Haag M; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Yoder BA; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Bunn PA; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Schenk EL; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Aisner DL; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado., Iams WT; Division of Medical Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Marmarelis ME; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Camidge DR; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado. |
| Source: | JTO clinical and research reports [JTO Clin Res Rep] 2024 Jan 18; Vol. 5 (2), pp. 100637. Date of Electronic Publication: 2024 Jan 18 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38361741 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Patil+T%22">Patil T</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Staley+A%22">Staley A</searchLink>; University of Colorado Cancer Center Biostatistics Core, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Nie+Y%22">Nie Y</searchLink>; Department of Medical Oncology, Yale School of Medicine, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Sakamoto+M%22">Sakamoto M</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Stalker+M%22">Stalker M</searchLink>; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Jurica+JM%22">Jurica JM</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Koehler+K%22">Koehler K</searchLink>; Division of Medical Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Cass+A%22">Cass A</searchLink>; Division of Medical Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Kuykendall+H%22">Kuykendall H</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Schmitt+E%22">Schmitt E</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Filar+E%22">Filar E</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Reventaite+E%22">Reventaite E</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Davies+KD%22">Davies KD</searchLink>; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Nijmeh+H%22">Nijmeh H</searchLink>; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Haag+M%22">Haag M</searchLink>; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Yoder+BA%22">Yoder BA</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Bunn+PA%22">Bunn PA</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Schenk+EL%22">Schenk EL</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Aisner+DL%22">Aisner DL</searchLink>; Department of Pathology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Iams+WT%22">Iams WT</searchLink>; Division of Medical Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Marmarelis+ME%22">Marmarelis ME</searchLink>; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Camidge+DR%22">Camidge DR</searchLink>; Division of Medical Oncology, University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101769967%22">JTO clinical and research reports</searchLink> [JTO Clin Res Rep] 2024 Jan 18; Vol. 5 (2), pp. 100637. <i>Date of Electronic Publication: </i>2024 Jan 18 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101769967 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-3643 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226663643%22">26663643 </searchLink><i>NLM ISO Abbreviation: </i>JTO Clin Res Rep <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38361741 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jtocrr.2024.100637 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100637 Titles: – TitleFull: The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Patil T – PersonEntity: Name: NameFull: Staley A – PersonEntity: Name: NameFull: Nie Y – PersonEntity: Name: NameFull: Sakamoto M – PersonEntity: Name: NameFull: Stalker M – PersonEntity: Name: NameFull: Jurica JM – PersonEntity: Name: NameFull: Koehler K – PersonEntity: Name: NameFull: Cass A – PersonEntity: Name: NameFull: Kuykendall H – PersonEntity: Name: NameFull: Schmitt E – PersonEntity: Name: NameFull: Filar E – PersonEntity: Name: NameFull: Reventaite E – PersonEntity: Name: NameFull: Davies KD – PersonEntity: Name: NameFull: Nijmeh H – PersonEntity: Name: NameFull: Haag M – PersonEntity: Name: NameFull: Yoder BA – PersonEntity: Name: NameFull: Bunn PA – PersonEntity: Name: NameFull: Schenk EL – PersonEntity: Name: NameFull: Aisner DL – PersonEntity: Name: NameFull: Iams WT – PersonEntity: Name: NameFull: Marmarelis ME – PersonEntity: Name: NameFull: Camidge DR IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 01 Text: 2024 Jan 18 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2666-3643 Numbering: – Type: volume Value: 5 – Type: issue Value: 2 Titles: – TitleFull: JTO clinical and research reports Type: main |
| ResultId | 1 |
